New chief financial officer for Symyx Technologies; DEM Solutions appoints new sales director for the Asia Pacific region; CEO of BioTek Instruments joins the board of directors of ALSSA.
Luc Missorten is a new director of LMS; Neil Chue Hong is the new director of Open Middleware Infrastructure Institute UK; and Agilent Technologies has appointed William Molnar as vp of its Strategene division.
Interactive Supercomputing (ISC) has named Bill Blake as it CEO, taking over from Pete Peterson, ISCs founder. Blake will be responsible for leading ISC through its next phase of growth.
Aureus Pharma has announced changes to its executive and supervisory boards. Jason Theodosiou, previously chief operating office at Aureus, has replaced André Michel as CEO.
Richard Solari, former director of business intelligence at Oracle, has joined InforSense as vice president of analytic solutions. Solari will be responsible for the companys overall expansion into new markets.
LMS has appointed Eddy Vandersmissen as vice president of marketing and customer services. He joins LMS from Fujitsu Siemens where he was marketing director for the Benelux region.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
